Israeli pharma giant Teva Israel wins tax battle before Delhi High Court against IT Department
Cite this
Citations are auto-generated; verify before publishing. The news classification is PolicyDhara's, not the source's.
News coverage — journalism about policy, not a policy document. Useful as timely context; the underlying instrument is linked where known.
Summary
In a major victory for Israeli pharmaceutical company Teva Israel, the Delhi High Court has held that a ₹1,851 crore payment made by Ranbaxy Laboratories to Teva Israel under a settlement agreement is not taxable in India [Teva Pharma Vs Union of India].By way of an order passed on September 15, a bench of Justices Dinesh Mehta and Vinod Kumar said the payment could not be taxed merely because it was made by an Indian company to a foreign entity.“Mere payment by an Indian resident to a non-resid